Clinical trials
Diabetes Mellitus, Type 2 trials in Colombia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
73 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 7 |
| 2010 | 13 |
| 2011 | 4 |
| 2012 | 5 |
| 2013 | 1 |
| 2014 | 6 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 61 |
| Not yet recruiting | 4 |
| Terminated | 4 |
| Recruiting | 2 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sanofi | 11 |
| Boehringer Ingelheim | 9 |
| AstraZeneca | 7 |
| Novo Nordisk A/S | 7 |
| Hospital Universitario San Ignacio | 5 |
| Janssen Research & Development, LLC | 5 |
| Novartis Pharmaceuticals | 4 |
| GlaxoSmithKline | 3 |
| Hoffmann-La Roche | 3 |
| Bayer | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 73 |
| Diabetes Mellitus | 12 |
| Cardiovascular Diseases | 5 |
| Glucose Metabolism Disorders | 4 |
| Renal Insufficiency, Chronic | 4 |
| Diabetic Nephropathies | 3 |
| Glucose Intolerance | 3 |
| Hyperglycemia | 3 |
| Kidney Diseases | 3 |
| Metabolic Diseases | 3 |
Trials
Showing 51 to 73 of 73. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.